Work

Dose-Escalation Phase I Study of Cabazitaxel (CBZ) + Gemcitabine (GEM) in Patients (PTS) with Metastatic or Unresectable Advanced Solid Malignancy

Year: 2012

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)33059-3

Authors: O. Rixe, I. Puzanov, P.M. LoRusso, J. Yin, S. Doroumian, X. Zhi, A.J. Olszanski

Institutions: Vanderbilt University, Vanderbilt University Medical Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Sanofi (United States), Sanofi (France), Fox Chase Cancer Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999558592

FWCI: 0.142

Cites:

Cited by: 1

Related to: 10